{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:32:19Z","timestamp":1790451139795,"version":"4.1.0"},"reference-count":163,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS105979"],"award-info":[{"award-number":["R01 NS105979"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-008252"],"award-info":[{"award-number":["MJFF-008252"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s13311-023-01433-w","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T16:33:37Z","timestamp":1694190817000},"page":"1653-1668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease"],"prefix":"10.1016","volume":"20","author":[{"given":"J\u00e1nos A.","family":"Barbero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashin","family":"Unadkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0854-864X","authenticated-orcid":false,"given":"David","family":"Eidelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-023-01433-w_bib1","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1212\/WNL.0000000000012246","article-title":"Long-term outcomes (15 years) after subthalamic nucleus deep brain stimulation in patients with Parkinson disease","volume":"97","author":"Bove","year":"2021","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01433-w_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419838096","article-title":"An update on best practice of deep brain stimulation in Parkinson's disease","volume":"12","author":"Hartmann","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1007\/s13311-023-01433-w_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13534-022-00226-y","article-title":"Deep brain stimulation for Parkinson's disease: a review and future outlook","volume":"12","author":"Malvea","year":"2022","journal-title":"Biomed Eng Lett"},{"key":"10.1007\/s13311-023-01433-w_bib4","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/2017.11.FOCUS17586","article-title":"Focused ultrasound in neurosurgery: a historical perspective","volume":"44","author":"Harary","year":"2018","journal-title":"Neurosurg Focus"},{"key":"10.1007\/s13311-023-01433-w_bib5","first-page":"8124624","article-title":"MRI-guided focused ultrasound in Parkinson's disease: a review","volume":"2017","author":"Schlesinger","year":"2017","journal-title":"Parkinsons Dis"},{"key":"10.1007\/s13311-023-01433-w_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","article-title":"AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial","volume":"10","author":"LeWitt","year":"2011","journal-title":"The Lancet Neurology"},{"key":"10.1007\/s13311-023-01433-w_bib7","doi-asserted-by":"crossref","first-page":"e90133","DOI":"10.1172\/jci.insight.90133","article-title":"Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease","volume":"2","author":"Niethammer","year":"2017","journal-title":"JCI Insight"},{"key":"10.1007\/s13311-023-01433-w_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.648532","article-title":"Gene therapy in movement disorders: a systematic review of ongoing and completed clinical trials","author":"Merola","year":"2021","journal-title":"Front Neurol [Internet]"},{"key":"10.1007\/s13311-023-01433-w_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41591-019-0507-2","article-title":"Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease","volume":"25","author":"Barker","year":"2019","journal-title":"Nat Med"},{"key":"10.1007\/s13311-023-01433-w_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.810860","article-title":"The disease modification conundrum in Parkinson's disease: failures and hopes","author":"Mari","year":"2022","journal-title":"Front Aging Neurosci [Internet]"},{"key":"10.1007\/s13311-023-01433-w_bib11","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/mds.20803","article-title":"Subjective report versus objective measurement of activities of daily living in Parkinson's disease","volume":"21","author":"Shulman","year":"2006","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00555","article-title":"How wearable sensors can support Parkinson's disease diagnosis and treatment: a systematic review","author":"Rovini","year":"2017","journal-title":"Front Neurosci [Internet]"},{"key":"10.1007\/s13311-023-01433-w_bib14","doi-asserted-by":"crossref","first-page":"e0183989","DOI":"10.1371\/journal.pone.0183989","article-title":"Wearable sensors objectively measure gait parameters in Parkinson's disease","volume":"12","author":"Schlachetzki","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-023-01433-w_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2967\/jnumed.109.066811","article-title":"Dopamine cell implantation in Parkinson's disease: long-term clinical and 18F-FDOPA PET outcomes","volume":"51","author":"Ma","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1007\/s13311-023-01433-w_bib16","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-023-01433-w_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mds.26907","article-title":"Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers","volume":"32","author":"Strafella","year":"2017","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib18","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/awm086","article-title":"Changes in network activity with the progression of Parkinson's disease","volume":"130","author":"Huang","year":"2007","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01433-w_bib19","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1523\/JNEUROSCI.4188-09.2010","article-title":"Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease","volume":"30","author":"Tang","year":"2010","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01433-w_bib20","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3233\/JPD-202117","article-title":"Hemispheric network expression in Parkinson's disease: relationship to dopaminergic asymmetries","volume":"10","author":"Tang","year":"2020","journal-title":"JPD"},{"key":"10.1007\/s13311-023-01433-w_bib21","doi-asserted-by":"crossref","first-page":"eaau0713","DOI":"10.1126\/scitranslmed.aau0713","article-title":"Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity","volume":"10","author":"Niethammer","year":"2018","journal-title":"Sci Transl Med."},{"key":"10.1007\/s13311-023-01433-w_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-022-00753-3","article-title":"Functional brain networks in the evaluation of patients with neurodegenerative disorders","volume":"19","author":"Perovnik","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1007\/s13311-023-01433-w_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.tins.2009.06.003","article-title":"Metabolic brain networks in neurodegenerative disorders: a functional imaging approach","volume":"32","author":"Eidelberg","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1007\/s13311-023-01433-w_bib24","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.neuroimage.2010.10.025","article-title":"Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues","volume":"54","author":"Spetsieris","year":"2011","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-023-01433-w_bib25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fnins.2019.00617","article-title":"Brain molecular connectivity in neurodegenerative diseases: recent advances and new perspectives using positron emission tomography","volume":"13","author":"Sala","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1007\/s13311-023-01433-w_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00259-019-04570-7","article-title":"Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts","volume":"47","author":"Meles","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s13311-023-01433-w_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hbm.460020108","article-title":"Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: a principal component approach to modeling brain function in disease","volume":"2","author":"Alexander","year":"1994","journal-title":"Hum Brain Mapp"},{"key":"10.1007\/s13311-023-01433-w_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12013-010-9093-0","article-title":"Multivariate data analysis for neuroimaging data: overview and application to Alzheimer's disease","volume":"58","author":"Habeck","year":"2010","journal-title":"Cell Biochem Biophys"},{"key":"10.1007\/s13311-023-01433-w_bib29","doi-asserted-by":"crossref","first-page":"117568","DOI":"10.1016\/j.neuroimage.2020.117568","article-title":"Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson's disease","volume":"226","author":"Spetsieris","year":"2021","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-023-01433-w_bib30","first-page":"4121","article-title":"Network structure and function in Parkinson's Disease","volume":"28","author":"Ko","year":"2018","journal-title":"Cereb Cortex"},{"key":"10.1007\/s13311-023-01433-w_bib31","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1162\/0899766053723023","article-title":"A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis","volume":"17","author":"Habeck","year":"2005","journal-title":"Neural Comput"},{"key":"10.1007\/s13311-023-01433-w_bib32","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/brain\/awq017","article-title":"Increased sensorimotor network activity in DYT1 dystonia: a functional imaging study","volume":"133","author":"Carbon","year":"2010","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01433-w_bib33","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.4331-11.2012","article-title":"Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation","volume":"32","author":"Mure","year":"2012","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01433-w_bib34","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1523\/JNEUROSCI.5024-12.2013","article-title":"Parkinson's disease: increased motor network activity in the absence of movement","volume":"33","author":"Ko","year":"2013","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01433-w_bib35","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1172\/JCI69411","article-title":"Metabolic network as a progression biomarker of premanifest Huntington's disease","volume":"123","author":"Tang","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-023-01433-w_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13137","article-title":"Longitudinal changes in metabolic network activity in early Alzheimer's disease","author":"Perovnik","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-023-01433-w_bib37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","article-title":"The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease","volume":"34","author":"Brakedal","year":"2022","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-023-01433-w_bib38","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1172\/JCI75073","article-title":"Network modulation following sham surgery in Parkinson's disease","volume":"124","author":"Ko","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-023-01433-w_bib39","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.neuroimage.2010.09.028","article-title":"Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects","volume":"54","author":"Mure","year":"2011","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-023-01433-w_bib40","doi-asserted-by":"crossref","first-page":"41583","DOI":"10.1038\/srep41583","article-title":"Volumetric spatial correlations of neurovascular coupling studied using single pulse opto-fMRI","volume":"7","author":"Christie","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-023-01433-w_bib41","series-title":"Medical Image Computing and Computer Assisted Intervention \u2013 MICCAI 2018","first-page":"190","article-title":"The dynamic measurements of regional brain activity for resting-state fMRI: d-ALFF, d-fALFF and d-ReHo","author":"Tang","year":"2018"},{"key":"10.1007\/s13311-023-01433-w_bib42","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.neuroimage.2004.03.027","article-title":"Validating the independent components of neuroimaging time series via clustering and visualization","volume":"22","author":"Himberg","year":"2004","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-023-01433-w_bib43","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/j.neuroimage.2008.10.057","article-title":"A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data","volume":"45","author":"Calhoun","year":"2009","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-023-01433-w_bib44","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/hbm.21170","article-title":"Comparison of multi-subject ICA methods for analysis of fMRI data","volume":"32","author":"Erhardt","year":"2010","journal-title":"Hum Brain Mapp"},{"key":"10.1007\/s13311-023-01433-w_bib45","doi-asserted-by":"crossref","first-page":"20110534","DOI":"10.1098\/rsta.2011.0534","article-title":"Independent component analysis: recent advances","volume":"371","author":"Hyv\u00e4rinen","year":"2013","journal-title":"Phil Trans R Soc A"},{"key":"10.1007\/s13311-023-01433-w_bib46","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/hbm.23260","article-title":"Parkinson's disease-related network topographies characterized with resting state functional MRI","volume":"38","author":"Vo","year":"2017","journal-title":"Hum Brain Mapp"},{"key":"10.1007\/s13311-023-01433-w_bib47","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1073\/pnas.0811879106","article-title":"Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele","volume":"106","author":"Filippini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01433-w_bib48","doi-asserted-by":"crossref","first-page":"100026","DOI":"10.1016\/j.ynirp.2021.100026","article-title":"Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation study","volume":"1","author":"Rommal","year":"2021","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-023-01433-w_bib49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.jcbfm.9600358","article-title":"Abnormal metabolic network activity in Parkinson's disease: test\u2013retest reproducibility","volume":"27","author":"Ma","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-023-01433-w_bib50","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.23631","article-title":"Metabolic brain networks in translational neurology: concepts and applications","volume":"72","author":"Niethammer","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-023-01433-w_bib51","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0271678X16637880","article-title":"Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations","volume":"37","author":"Ko","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-023-01433-w_bib52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1474-4422(18)30169-8","article-title":"Network imaging biomarkers: insights and clinical applications in Parkinson's disease","volume":"17","author":"Schindlbeck","year":"2018","journal-title":"The Lancet Neurology"},{"key":"10.1007\/s13311-023-01433-w_bib53","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nicl.2018.08.006","article-title":"FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease","volume":"20","author":"Matthews","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1007\/s13311-023-01433-w_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/mds.27960","article-title":"Metabolic network abnormalities in drug-na\u00efve Parkinson's disease","volume":"35","author":"Schindlbeck","year":"2020","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib55","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/mds.28217","article-title":"Multicenter validation of metabolic abnormalities related to PSP according to the MDS-PSP criteria","volume":"35","author":"Mart\u00ed-Andr\u00e9s","year":"2020","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib56","doi-asserted-by":"crossref","first-page":"e88119","DOI":"10.1371\/journal.pone.0088119","article-title":"Quantifying significance of topographical similarities of disease-related brain metabolic patterns","volume":"9","author":"Ko","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-023-01433-w_bib57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00234-017-1821-3","article-title":"Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample","volume":"59","author":"Tom\u0161e","year":"2017","journal-title":"Neuroradiology"},{"key":"10.1007\/s13311-023-01433-w_bib58","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2967\/jnumed.120.257345","article-title":"Dynamic 18F-FPCIT PET: Quantification of Parkinson's disease metabolic networks and nigrostriatal dopaminergic dysfunction in a single imaging session","volume":"62","author":"Peng","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1007\/s13311-023-01433-w_bib59","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/hbm.22863","article-title":"Dopaminergic correlates of metabolic network activity in Parkinson's disease","volume":"36","author":"Holtbernd","year":"2015","journal-title":"Hum Brain Mapp"},{"key":"10.1007\/s13311-023-01433-w_bib60","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/RLU.0000000000002148","article-title":"Clinical, dopaminergic, and metabolic correlations in Parkinson disease: a dual-tracer PET study","volume":"43","author":"Liu","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s13311-023-01433-w_bib61","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/mds.27945","article-title":"Metabolic correlates of dopaminergic loss in dementia with lewy bodies","volume":"35","author":"Huber","year":"2020","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib62","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/brain\/awn031","article-title":"Metabolic correlates of subthalamic nucleus activity in Parkinson's disease","volume":"131","author":"Lin","year":"2008","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01433-w_bib63","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01433-w_bib64","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.0000000000000130","article-title":"Abnormal metabolic network activity in REM sleep behavior disorder","volume":"82","author":"Holtbernd","year":"2014","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01433-w_bib65","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1093\/brain\/awu290","article-title":"Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder","volume":"137","author":"Wu","year":"2014","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01433-w_bib66","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/mds.27094","article-title":"FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder","volume":"32","author":"Meles","year":"2017","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib67","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/mds.28260","article-title":"Four-year follow-up of [18F]Fluorodeoxyglucose positron emission tomography-based Parkinson's disease-related pattern expression in 20 patients with isolated rapid eye movement sleep behavior disorder shows prodromal progression","volume":"36","author":"Kogan","year":"2021","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib68","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/0271678X19828916","article-title":"Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder","volume":"40","author":"Huang","year":"2020","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-023-01433-w_bib69","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.1212\/WNL.0000000000012228","article-title":"Parkinson disease-related brain metabolic patterns and neurodegeneration in isolated REM sleep behavior disorder","volume":"97","author":"Shin","year":"2021","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01433-w_bib70","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.parkreldis.2018.12.016","article-title":"Resting-state fMRI in Parkinson's disease patients with cognitive impairment: a meta-analysis","volume":"62","author":"Wolters","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-023-01433-w_bib71","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1073\/pnas.1411011112","article-title":"Metabolic resting-state brain networks in health and disease","volume":"112","author":"Spetsieris","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-023-01433-w_bib72","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1002\/hbm.25393","article-title":"The default mode network and cognition in Parkinson's disease: a multimodal resting-state network approach","volume":"42","author":"Ruppert","year":"2021","journal-title":"Hum Brain Mapp"},{"key":"10.1007\/s13311-023-01433-w_bib73","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroimage.2006.09.003","article-title":"Metabolic brain networks associated with cognitive function in Parkinson's disease","volume":"34","author":"Huang","year":"2007","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-023-01433-w_bib74","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1212\/WNL.0b013e31822c6224","article-title":"Network correlates of the cognitive response to levodopa in Parkinson disease","volume":"77","author":"Mattis","year":"2011","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01433-w_bib75","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/jcbfm.2015.112","article-title":"Abnormal metabolic pattern associated with cognitive impairment in Parkinson's disease: a validation study","volume":"35","author":"Meles","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-023-01433-w_bib76","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1212\/WNL.0000000000003285","article-title":"Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases","volume":"87","author":"Mattis","year":"2016","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01433-w_bib77","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1093\/cercor\/bhab148","article-title":"Cognition-related functional topographies in Parkinson's disease: localized loss of the ventral default mode network","volume":"31","author":"Schindlbeck","year":"2021","journal-title":"Cereb Cortex"},{"key":"10.1007\/s13311-023-01433-w_bib78","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/01.wnl.0000304050.05332.9c","article-title":"Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease","volume":"70","author":"Huang","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01433-w_bib79","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/mds.29188","article-title":"Stereotyped relationship between motor and cognitive metabolic networks in Parkinson's disease","volume":"37","author":"Rus","year":"2022","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-023-01433-w_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","article-title":"A timeline for Parkinson's disease","volume":"16","author":"Hawkes","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-023-01433-w_bib82","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","article-title":"A critical evaluation of the braak staging scheme for Parkinson's disease","volume":"64","author":"Burke","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-023-01433-w_bib83","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01433-w_bib84","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/mds.27485","article-title":"Importance of low diagnostic accuracy for early Parkinson's disease","volume":"33","author":"Beach","year":"2018","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-8-42","article-title":"The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans","volume":"8","author":"Vlaar","year":"2008","journal-title":"BMC Neurol"},{"key":"10.1007\/s13311-023-01433-w_bib86","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archneur.63.8.1154","article-title":"Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]\u03b2-CIT SPECT analysis","volume":"63","author":"Seppi","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-023-01433-w_bib87","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1212\/CON.0000000000000348","article-title":"Diagnostic approach to atypical parkinsonian syndromes","volume":"22","author":"McFarland","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1007\/s13311-023-01433-w_bib88","first-page":"61","article-title":"The differential diagnosis and treatment of atypical parkinsonism","volume":"113","author":"Levin","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"10.1007\/s13311-023-01433-w_bib89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ene.13412","article-title":"Atypical parkinsonian syndromes: a general neurologist's perspective","volume":"25","author":"Deutschl\u00e4nder","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1007\/s13311-023-01433-w_bib90","series-title":"Parkinsonism-plus syndromes and secondary parkinsonian disorders. Principles and practice of movement disorders","first-page":"233","author":"Fahn","year":"2007"},{"key":"10.1007\/s13311-023-01433-w_bib91","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.neuroimage.2005.03.012","article-title":"FDG PET in the differential diagnosis of parkinsonian disorders","volume":"26","author":"Eckert","year":"2005","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-023-01433-w_bib92","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mds.21933","article-title":"Abnormal metabolic networks in atypical parkinsonism","volume":"23","author":"Eckert","year":"2008","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib93","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.0b013e318250d7fd","article-title":"Network correlates of disease severity in multiple system atrophy","volume":"78","author":"Poston","year":"2012","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01433-w_bib94","doi-asserted-by":"crossref","first-page":"102416","DOI":"10.1016\/j.nicl.2020.102416","article-title":"Reproducible metabolic topographies associated with multiple system atrophy: Network and regional analyses in Chinese and American patient cohorts","volume":"28","author":"Shen","year":"2020","journal-title":"Neuroimage Clin."},{"key":"10.1007\/s13311-023-01433-w_bib95","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejmp.2022.04.016","article-title":"Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy","volume":"98","author":"Tom\u0161e","year":"2022","journal-title":"Physica Med"},{"key":"10.1007\/s13311-023-01433-w_bib96","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1002\/hbm.24044","article-title":"Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts","volume":"39","author":"Ge","year":"2018","journal-title":"Hum Brain Mapp"},{"key":"10.1007\/s13311-023-01433-w_bib97","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1093\/brain\/awu256","article-title":"A disease-specific metabolic brain network associated with corticobasal degeneration","volume":"137","author":"Niethammer","year":"2014","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01433-w_bib98","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1474-4422(10)70002-8","article-title":"Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis","volume":"9","author":"Tang","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01433-w_bib99","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2967\/jnumed.115.161992","article-title":"Automated differential diagnosis of early parkinsonism using metabolic brain networks: a validation study","volume":"57","author":"Tripathi","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1007\/s13311-023-01433-w_bib100","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1007\/s00259-020-04785-z","article-title":"Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns' based approach","volume":"47","author":"Rus","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s13311-023-01433-w_bib101","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1038\/s41598-022-06663-0","article-title":"A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism","volume":"12","author":"Papathoma","year":"2022","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-023-01433-w_bib102","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1007\/s00259-021-05302-6","article-title":"Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism","volume":"48","author":"Schindlbeck","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s13311-023-01433-w_bib103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s10020-021-00279-2","article-title":"Novel targeted therapies for Parkinson's disease","volume":"27","author":"Ntetsika","year":"2021","journal-title":"Mol Med"},{"key":"10.1007\/s13311-023-01433-w_bib104","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/brain\/awl162","article-title":"Network modulation in the treatment of Parkinson's disease","volume":"129","author":"Asanuma","year":"2006","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01433-w_bib105","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1523\/JNEUROSCI.0582-08.2008","article-title":"Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease","volume":"28","author":"Hirano","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01433-w_bib106","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00415-009-5267-3","article-title":"Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease","volume":"257","author":"Wang","year":"2010","journal-title":"J Neurol"},{"key":"10.1007\/s13311-023-01433-w_bib107","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13550-020-00722-1","article-title":"Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson's disease: a longitudinal study","volume":"10","author":"Ge","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1007\/s13311-023-01433-w_bib108","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuroimage.2005.12.024","article-title":"Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease","volume":"31","author":"Tro\u0161t","year":"2006","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-023-01433-w_bib109","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00259-019-04497-z","article-title":"Functional impact of subthalamotomy by magnetic resonance\u2013guided focused ultrasound in Parkinson's disease: a hybrid PET\/MR study of resting-state brain metabolism","volume":"47","author":"Rodriguez-Rojas","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s13311-023-01433-w_bib110","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3171\/2008.12.JNS08991","article-title":"Assessing the microlesion effect of subthalamic deep brain stimulation surgery with FDG PET: Clinical article","volume":"110","author":"Pourfar","year":"2009","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-023-01433-w_bib111","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/brain\/124.8.1601","article-title":"Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism","volume":"124","author":"Fukuda","year":"2001","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01433-w_bib112","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/brain\/aws023","article-title":"Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?","volume":"135","author":"Helmich","year":"2012","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01433-w_bib113","doi-asserted-by":"crossref","first-page":"e1461","DOI":"10.1212\/WNL.0000000000010316","article-title":"Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease","volume":"95","author":"Zach","year":"2020","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01433-w_bib114","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1007\/s13311-022-01294-9","article-title":"Treatment-specific network modulation of MRI-guided focused ultrasound thalamotomy in essential tremor : modulation of ET-related network by MRgFUS thalamotomy","volume":"19","author":"Xiong","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1007\/s13311-023-01433-w_bib115","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mds.22870","article-title":"Imaging essential tremor","volume":"25","author":"Isaias","year":"2010","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib116","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s13311-022-01321-9","article-title":"Commentary on: a network approach to understanding the effects of focused ultrasound for essential tremor: insights into pathophysiology, treatment, and imaging biomarkers","volume":"19","author":"Unadkat","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1007\/s13311-023-01433-w_bib117","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"10.1007\/s13311-023-01433-w_bib118","doi-asserted-by":"crossref","first-page":"19559","DOI":"10.1073\/pnas.0706006104","article-title":"Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease","volume":"104","author":"Feigin","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-023-01433-w_bib119","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/cercor\/bhac110","article-title":"Adaptive and pathological connectivity responses in Parkinson's disease brain networks","volume":"33","author":"Vo","year":"2023","journal-title":"Cereb Cortex"},{"key":"10.1007\/s13311-023-01433-w_bib120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4939-1875-1_4","article-title":"NAD+ content and its role in mitochondria","volume":"1241","author":"Li","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1007\/s13311-023-01433-w_bib121","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s40478-022-01424-6","article-title":"Mitochondrial dysfunction is a key pathological driver of early stage Parkinson's","volume":"10","author":"Toomey","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-023-01433-w_bib122","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD+ in brain aging and neurodegenerative disorders","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-023-01433-w_bib123","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/mds.21894","article-title":"Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib124","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1093\/brain\/awn116","article-title":"Placebo effects: clinical aspects and neurobiology","volume":"131","author":"Oken","year":"2008","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01433-w_bib125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3923","article-title":"The placebo response in medicine: minimize, maximize or personalize?","volume":"12","author":"Enck","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1007\/s13311-023-01433-w_bib126","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2013.07.009","article-title":"Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions","volume":"140","author":"Murray","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1007\/s13311-023-01433-w_bib127","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/mds.27438","article-title":"Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going","volume":"33","author":"Quattrone","year":"2018","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib128","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrn3976","article-title":"The neuroscience of placebo effects: connecting context, learning and health","volume":"16","author":"Wager","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s13311-023-01433-w_bib129","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/mds.27416","article-title":"What influences placebo and nocebo responses in Parkinson's disease?","volume":"33","author":"Witek","year":"2018","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib130","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1126\/science.1060937","article-title":"Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease","volume":"293","author":"de la Fuente-Fern\u00e1ndez","year":"2001","journal-title":"Science"},{"key":"10.1007\/s13311-023-01433-w_bib131","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0166-2236(02)02181-1","article-title":"The placebo effect in Parkinson's disease","volume":"25","author":"de la Fuente-Fern\u00e1ndez","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.1007\/s13311-023-01433-w_bib132","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archgenpsychiatry.2010.88","article-title":"Effects of expectation on placebo-induced dopamine release in Parkinson disease","volume":"67","author":"Lidstone","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1007\/s13311-023-01433-w_bib133","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nn1250","article-title":"Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus","volume":"7","author":"Benedetti","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-023-01433-w_bib134","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1113\/jphysiol.2009.169425","article-title":"Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response","volume":"587","author":"Benedetti","year":"2009","journal-title":"J Physiol"},{"key":"10.1007\/s13311-023-01433-w_bib135","article-title":"Placebo response in Parkinson's disease (PD) is predicted by expression levels of a specific brain network [abstract]","author":"Barbero","year":"2023","journal-title":"Mov Disord."},{"key":"10.1007\/s13311-023-01433-w_bib136","article-title":"Nicotinamide riboside supplementation for early Parkinson's disease: Clinical benefit correlates with a distinct resting state network [abstract]","author":"Barbero","year":"2023","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-023-01433-w_bib137","article-title":"Modulation of a subthalamic nucleus related network associated with motor response following Deep Brain Stimulation [abstract]","author":"Unadkat","year":"2023","journal-title":"Mov Disord."},{"key":"10.1007\/s13311-023-01433-w_bib138","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/cercor\/bhz280","article-title":"LRRK2 and GBA variants exert distinct influences on Parkinson's disease-specific metabolic networks","volume":"30","author":"Schindlbeck","year":"2020","journal-title":"Cereb Cortex"},{"key":"10.1007\/s13311-023-01433-w_bib139","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1093\/cercor\/bhad012","article-title":"Disordered network structure and function in dystonia: pathological connectivity vs. adaptive responses","volume":"33","author":"Vo","year":"2023","journal-title":"Cereb Cortex"},{"key":"10.1007\/s13311-023-01433-w_bib140","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1073\/pnas.1513752113","article-title":"Metabolic connectivity mapping reveals effective connectivity in the resting human brain","volume":"113","author":"Riedl","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01433-w_bib141","doi-asserted-by":"crossref","first-page":"60S","DOI":"10.2967\/jnumed.121.263201","article-title":"Imaging of synaptic density in neurodegenerative disorders","volume":"63","author":"Carson","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1007\/s13311-023-01433-w_bib142","doi-asserted-by":"crossref","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","article-title":"Imaging synaptic density in the living human brain","volume":"8","author":"Finnema","year":"2016","journal-title":"Sci Transl Med."},{"key":"10.1007\/s13311-023-01433-w_bib143","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ana.25682","article-title":"Synaptic changes in Parkinson disease assessed with in vivo imaging","volume":"87","author":"Matuskey","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-023-01433-w_bib144","doi-asserted-by":"crossref","first-page":"118167","DOI":"10.1016\/j.neuroimage.2021.118167","article-title":"Identifying brain networks in synaptic density PET (11C-UCB-J) with independent component analysis","volume":"237","author":"Fang","year":"2021","journal-title":"Neuroimage"},{"key":"10.1007\/s13311-023-01433-w_bib145","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96411","article-title":"Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia","volume":"2","author":"Jourdain","year":"2017","journal-title":"JCI Insight"},{"key":"10.1007\/s13311-023-01433-w_bib146","doi-asserted-by":"crossref","first-page":"e86615","DOI":"10.1172\/jci.insight.86615","article-title":"Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia","volume":"1","author":"Jourdain","year":"2016","journal-title":"JCI Insight"},{"key":"10.1007\/s13311-023-01433-w_bib147","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/mds.26715","article-title":"Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification","volume":"31","author":"Huppertz","year":"2016","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-023-01433-w_bib148","doi-asserted-by":"crossref","first-page":"136921","DOI":"10.1155\/2015\/136921","article-title":"Classification of Parkinsonian syndromes from FDG-PET brain data using decision trees with SSM\/PCA features","volume":"2015","author":"Mudali","year":"2015","journal-title":"Comput Math Methods Med"},{"key":"10.1007\/s13311-023-01433-w_bib149","doi-asserted-by":"crossref","first-page":"1950010","DOI":"10.1142\/S0129065719500102","article-title":"Scaled subprofile modeling and convolutional neural networks for the identification of Parkinson's disease in 3D nuclear imaging data","volume":"29","author":"Manzanera","year":"2019","journal-title":"Int J Neural Syst"},{"key":"10.1007\/s13311-023-01433-w_bib150","article-title":"Attention is all you need","author":"Vaswani","year":"2017","journal-title":"Adv Neural Inf Proces Syst [Internet]"},{"key":"10.1007\/s13311-023-01433-w_bib151","doi-asserted-by":"crossref","first-page":"105482","DOI":"10.1016\/j.engappai.2022.105482","article-title":"Improvement of Performance in Freezing of Gait detection in Parkinson's Disease using Transformer networks and a single waist-worn triaxial accelerometer","volume":"116","author":"Sigcha","year":"2022","journal-title":"Eng Appl Artif Intell"},{"key":"10.1007\/s13311-023-01433-w_bib152","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1049\/ipr2.12820","article-title":"A coordinate attention enhanced swin transformer for handwriting recognition of Parkinson's disease","volume":"17","author":"Wang","year":"2023","journal-title":"IET Image Proc"},{"key":"10.1007\/s13311-023-01433-w_bib153","doi-asserted-by":"crossref","unstructured":"Mohaghegh M, Gascon J. Identifying Parkinson's disease using multimodal approach and deep learning. 2021 6th International Conference on Innovative Technology in Intelligent System and Industrial Applications (CITISIA). 2021. p. 1\u20136.","DOI":"10.1109\/CITISIA53721.2021.9719945"},{"key":"10.1007\/s13311-023-01433-w_bib154","doi-asserted-by":"crossref","first-page":"101672","DOI":"10.1109\/ACCESS.2022.3201843","article-title":"BERT learns from electroencephalograms about Parkinson's disease: transformer-based models for aid diagnosis","volume":"10","author":"Nogales","year":"2022","journal-title":"IEEE Access"},{"key":"10.1007\/s13311-023-01433-w_bib155","series-title":"Understanding robustness of transformers for image classification","first-page":"10231","author":"Bhojanapalli","year":"2021"},{"key":"10.1007\/s13311-023-01433-w_bib156","series-title":"General multi-label image classification with transformers","first-page":"16478","author":"Lanchantin","year":"2021"},{"key":"10.1007\/s13311-023-01433-w_bib157","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/diagnostics11081384","article-title":"TransMed: Transformers advance multi-modal medical image classification","volume":"11","author":"Dai","year":"2021","journal-title":"Diagnostics"},{"key":"10.1007\/s13311-023-01433-w_bib158","doi-asserted-by":"crossref","first-page":"1005731","DOI":"10.3389\/fnagi.2022.1005731","article-title":"Automated differential diagnosis of dementia syndromes using FDG PET and machine learning","volume":"14","author":"Perovnik","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1007\/s13311-023-01433-w_bib159","article-title":"Machine learning diagnosis of parkinsonian syndromes: network approach with two different sites [abstract]","author":"Perovnik","year":"2023","journal-title":"Mov Disord."},{"key":"10.1007\/s13311-023-01433-w_bib160","series-title":"Computer Vision \u2013 ECCV 2022","first-page":"220","article-title":"Training vision transformers with only 2040 images","author":"Cao","year":"2022"},{"key":"10.1007\/s13311-023-01433-w_bib161","article-title":"Vision transformer for small-size datasets [Internet]","author":"Lee","year":"2021","journal-title":"arXiv.org."},{"key":"10.1007\/s13311-023-01433-w_bib162","article-title":"Vision transformers: state of the art and research challenges [Internet]","author":"Ruan","year":"2022","journal-title":"arXiv.org."},{"key":"10.1007\/s13311-023-01433-w_bib163","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.neuroimage.2018.10.003","article-title":"Machine learning in neuroimaging: Progress and challenges","volume":"197","author":"Davatzikos","year":"2019","journal-title":"Neuroimage"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01433-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01433-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923020044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923020044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01433-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:18:24Z","timestamp":1761808704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923020044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":163,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1878747923020044"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01433-w","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01433-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}